Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch

Reuters

09/12

Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch

Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult "almost-pumpers" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1072005) on September 11, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2566919568"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566919568\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566919568?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-12 04:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566919568","market":"nz","top_or_hot":-1,"title":"Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult \"almost-pumpers\" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1072005) on September 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-09-12 04:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult \"almost-pumpers\" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1072005) on September 11, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MODD","symbol_name":"Modular Medical, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDLW6GWC:1","article_id":"2566919568","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566919568","pubTimestamp":1757621138,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult \"almost-pumpers\" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MODD":"Modular Medical, Inc.","BK4082":"医疗保健设备"},"translate_title":"Modular Medical Inc.宣布成功完成MODD1泵的临床研究，为Pivot泵的推出铺平道路","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MODD":0.9},"content_text":"Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch\n    \n\n        Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult \"almost-pumpers\" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1072005) on September 11, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}